Stockreport

How The Akebia Therapeutics (AKBA) Narrative Is Shifting After Vafseo Revenue And Protocol Updates [Yahoo! Finance]

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF Akebia Therapeutics' fair value target is held at US$4.40 per share, with the latest model keeping this figure steady versus the prior view. That lack of movement comes [Read more]